Adenosine receptor signaling: a key to opening the blood–brain door

Abstract : AbstractThe aim of this review is to outline evidence that adenosine receptor (AR) activation can modulate blood–brain barrier (BBB) permeability and the implications for disease states and drug delivery. Barriers of the central nervous system (CNS) constitute a protective and regulatory interface between the CNS and the rest of the organism. Such barriers allow for the maintenance of the homeostasis of the CNS milieu. Among them, the BBB is a highly efficient permeability barrier that separates the brain micro-environment from the circulating blood. It is made up of tight junction-connected endothelial cells with specialized transporters to selectively control the passage of nutrients required for neural homeostasis and function, while preventing the entry of neurotoxic factors. The identification of cellular and molecular mechanisms involved in the development and function of CNS barriers is required for a better understanding of CNS homeostasis in both physiological and pathological settings. It has long been recognized that the endogenous purine nucleoside adenosine is a potent modulator of a large number of neurological functions. More recently, experimental studies conducted with human/mouse brain primary endothelial cells as well as with mouse models, indicate that adenosine markedly regulates BBB permeability. Extracellular adenosine, which is efficiently generated through the catabolism of ATP via the CD39/CD73 ecto-nucleotidase axis, promotes BBB permeability by signaling through A1 and A2A ARs expressed on BBB cells. In line with this hypothesis, induction of AR signaling by selective agonists efficiently augments BBB permeability in a transient manner and promotes the entry of macromolecules into the CNS. Conversely, antagonism of AR signaling blocks the entry of inflammatory cells and soluble factors into the brain. Thus, AR modulation of the BBB appears as a system susceptible to tighten as well as to permeabilize the BBB. Collectively, these findings point to AR manipulation as a pertinent avenue of research for novel strategies aiming at efficiently delivering therapeutic drugs/cells into the CNS, or at restricting the entry of inflammatory immune cells into the brain in some diseases such as multiple sclerosis.
Type de document :
Article dans une revue
Fluids and Barriers of the CNS, BioMed Central, 2015, 12 (1), pp.20. 〈10.1186/s12987-015-0017-7〉
Liste complète des métadonnées

Littérature citée [101 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01264514
Contributeur : Bmc Bmc <>
Soumis le : vendredi 29 janvier 2016 - 12:43:40
Dernière modification le : jeudi 8 février 2018 - 11:10:16
Document(s) archivé(s) le : vendredi 11 novembre 2016 - 20:45:53

Fichier

12987_2015_Article_17.pdf
Publication financée par une institution

Identifiants

Collections

Citation

Margaret Bynoe, Christophe Viret, Angela Yan, Do-Geun Kim. Adenosine receptor signaling: a key to opening the blood–brain door. Fluids and Barriers of the CNS, BioMed Central, 2015, 12 (1), pp.20. 〈10.1186/s12987-015-0017-7〉. 〈inserm-01264514〉

Partager

Métriques

Consultations de la notice

57

Téléchargements de fichiers

116